DR. DAVID PLEASURE, MD
Neurology at Stockton Blvd, Sacramento, CA

License number
California G87568
Category
Neurology
Type
Neurology
Address
Address 2
2425 Stockton Blvd, Sacramento, CA 95817
861 Malaga Ave, Davis, CA 95616
Phone
(916) 453-2331
(530) 297-7985

Organization information

See more information about DAVID PLEASURE at bizstanding.com

David Pleasure MD

861 Malaga Ave, Davis, CA 95616

Industry:
Physician Peer/Grant Reviewer
Owner:
David Pleasure Owner, inactive

Professional information

David E Pleasure Photo 1

David E Pleasure, Sacramento CA

Specialties:
Neurologist
Address:
2425 Stockton Blvd, Sacramento, CA 95817
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)


David Pleasure Photo 2

Dr. David Pleasure, Sacramento CA - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
UC Davis Med Ctr Nrlgy Clin
4860 Y St STE 1100, Sacramento 95817
(916) 734-3588 (Phone)
Certifications:
Neurology, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1963
University Vt
Columbia Presby Med Center
Graduated: 1966
National Institute Health
Graduated: 1969


David Pleasure Photo 3

Intracellular Toll-Like Receptors Pathways And Axonal Degeneration

US Patent:
2012020, Aug 16, 2012
Filed:
Jan 30, 2012
Appl. No.:
13/361018
Inventors:
Athena Soulika - Sacramento CA, US
David Pleasure - Sacramento CA, US
International Classification:
A61K 39/395, A61K 31/47, A61K 31/517, A61K 31/55, A61K 31/44, A61K 31/7088, A61K 31/551, A61P 33/10, A61P 33/02, A61P 31/12, A61P 25/00, A61P 37/06, A61K 38/17, A61K 31/135
US Classification:
4241721, 514 177, 514311, 5142661, 514217, 514656, 514324, 51421402, 514 44 A
Abstract:
The present invention is directed to the identification of novel mechanisms involved in the initiation and spreading of axonal degeneration. In particular, the instant invention relates to the identification of a relationship between Toll-Like Receptors (TLRs) and axonal degeneration and the use of TLR inhibitors as antagonists of axonal degeneration.